However, more serious but rare side effects exist, making open communication with your doctor vital
In the ELIXA CVOT, lixisenatide was found to be non-inferior to standard of care plus placebo in terms of risk of the composite endpoint (cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina)13.4% in the lixisenatide group and 13.2% in the placebo group (hazard ratio, 1.02
Kidney conditions, ulcers, blood thinners, blood-pressure concerns, and other medications can affect what is safe
Symptoms of myelopathy include muscle weakness, numbness, tingling, difficulties sensing touch and balance problems
You are traveling internationally and have not yet confirmed documentation requirements for your destination
Buyer Takeaway: You're enrolling in a three-entity structure consistent with common telehealth prescription-program architecture: platform, clinical provider group, and pharmacy provider